Chiusura precedente | 5,56 |
Aperto | 5,51 |
Denaro | 5,61 x 400 |
Lettera | 5,70 x 100 |
Min-Max giorno | 5,45 - 5,65 |
Intervallo di 52 settimane | 5,45 - 14,37 |
Volume | |
Media Volume | 620.441 |
Capitalizzazione | 330,588M |
Beta (5 anni mensile) | 1,29 |
Rapporto PE (ttm) | N/D |
EPS (ttm) | -2,09 |
Prossima data utili | 07 mag 2024 - 13 mag 2024 |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | 11,93 |
SALT LAKE CITY, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of Investor Relations and FP&A, will participate in the Wells Fargo Healthcare Conference, being held in Boston, including a fireside chat presentation on Thursday, September 7, 2023 at 3:45pm EST. About
Health Catalyst Q2 2023 Financial Highlights & Key Themes August 8, 2023 SALT LAKE CITY, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended June 30, 2023. “For the second quarter of 2023, we are encouraged by our financial results, including total revenue of $73.2 million and Adjusted EBITDA of $3.5 million, w
SALT LAKE CITY, July 24, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2023 operating results on Tuesday, August 8, 2023, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialing 800-225-9448 fo